Literature DB >> 21938407

Proteomic analysis of circulating human monocytes in coronary artery disease.

Aruna Poduri1, Ajay Bahl, Kewal K Talwar, Madhu Khullar.   

Abstract

Monocytes play an important role in inflammation and atherosclerosis; however, the molecular details underlying these diverse functions are not completely understood. Proteomic analysis of monocytes can provide new insights into their biological role in coronary artery disease (CAD). Twenty angiographically confirmed male, CAD patients (≥50% stenosis) attending cardiology clinic of Nehru Hospital, PGIMER, Chandigarh, and who were not receiving any lipid lowering therapy and 20 TMT negative subjects who served as controls were enrolled in the study. Circulating monocytes isolated from overnight fasting blood samples were analyzed by 2D gel electrophoresis (pH 4-7), and differentially expressed protein spots were subjected to mass spectrometry and identification of proteins. We observed 333 ± 40 protein spots in monocytes from patients and 312 ± 20 in controls; out of which 63 protein spots showed altered intensity in CAD patients. Thirteen spots showed fivefold increased and two protein spots showed fivefold decreased expression in CAD group as compared to control group, respectively. Two proteins showing decreased expression in monocytes from CAD patients were identified as: (i) glutathione transferase and (ii) heat shock protein 70 KDa. Proteins showing increased expression in CAD patients were identified as: (i) vimentin, (ii) mannose binding lectin receptor protein, and (iii) S100A8 calcium-binding protein. The results of our study offer identification of several proteins in monocytes which can provide new perspectives in role of monocytes in pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21938407     DOI: 10.1007/s11010-011-1055-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  43 in total

1.  Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation.

Authors:  Riina Oksjoki; Hanna Jarva; Petri T Kovanen; Petri Laine; Seppo Meri; Markku O Pentikäinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-23       Impact factor: 8.311

Review 2.  Rab proteins, connecting transport and vesicle fusion.

Authors:  Ingrid Jordens; Marije Marsman; Coen Kuijl; Jacques Neefjes
Journal:  Traffic       Date:  2005-12       Impact factor: 6.215

3.  Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile.

Authors:  María G Barderas; José Tuñón; Verónica M Dardé; Fernando De la Cuesta; María C Durán; José J Jiménez-Nácher; Nieves Tarín; Lorenzo López-Bescós; Jesús Egido; Fernando Vivanco
Journal:  J Proteome Res       Date:  2007-02       Impact factor: 4.466

4.  Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis.

Authors:  Walter S Speidl; Markus Exner; Jasmin Amighi; Stefan P Kastl; Gerlinde Zorn; Gerald Maurer; Oswald Wagner; Kurt Huber; Erich Minar; Johann Wojta; Martin Schillinger
Journal:  Eur Heart J       Date:  2005-05-25       Impact factor: 29.983

5.  Chemical induction of cellular antioxidants affords marked protection against oxidative injury in vascular smooth muscle cells.

Authors:  Zhuoxiao Cao; Yunbo Li
Journal:  Biochem Biophys Res Commun       Date:  2002-03-22       Impact factor: 3.575

6.  Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome.

Authors:  María G Barderas; José Tuñón; Verónica M Dardé; Fernando De la Cuesta; José J Jiménez-Nácher; Nieves Tarín; Lorenzo López-Bescós; Jesús Egido; Fernando Vivanco
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

Review 7.  Mannan-binding lectin--a soluble pattern recognition molecule.

Authors:  Mihaela Gadjeva; Kazue Takahashi; Steffen Thiel
Journal:  Mol Immunol       Date:  2004-06       Impact factor: 4.407

8.  Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women.

Authors:  Tymen T Keller; Sander I van Leuven; Marijn C Meuwese; Nicholas J Wareham; Robert Luben; Erik S Stroes; C Erik Hack; Marcel Levi; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-10       Impact factor: 8.311

9.  Complement receptor 1/CD35 is a receptor for mannan-binding lectin.

Authors:  I Ghiran; S F Barbashov; L B Klickstein; S W Tas; J C Jensenius; A Nicholson-Weller
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

10.  C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.

Authors:  C A Ogden; A deCathelineau; P R Hoffmann; D Bratton; B Ghebrehiwet; V A Fadok; P M Henson
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  3 in total

1.  Characterization of a human 12/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein.

Authors:  Susmita Samanta; Kurtis Anderson; Sean Moran; David Hawke; David Gorenstein; Myriam Fornage
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

2.  Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine.

Authors:  Shih-Yi Lin; Wu-Huei Hsu; Cheng-Chieh Lin; Chao-Jung Chen
Journal:  Biomedicine (Taipei)       Date:  2014-11-13

Review 3.  Proteomics in India: the clinical aspect.

Authors:  Somaditya Mukherjee; Arun Bandyopadhyay
Journal:  Clin Proteomics       Date:  2016-11-05       Impact factor: 3.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.